Regenxbio (RGNX) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to -$274.2 million.
- Regenxbio's Enterprise Value fell 733.77% to -$274.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$274.2 million, marking a year-over-year decrease of 733.77%. This contributed to the annual value of -$234.7 million for FY2024, which is 1473.93% up from last year.
- As of Q3 2025, Regenxbio's Enterprise Value stood at -$274.2 million, which was down 733.77% from -$323.3 million recorded in Q2 2025.
- In the past 5 years, Regenxbio's Enterprise Value registered a high of -$234.7 million during Q4 2024, and its lowest value of -$457.4 million during Q4 2021.
- Moreover, its 5-year median value for Enterprise Value was -$331.8 million (2023), whereas its average is -$335.3 million.
- Per our database at Business Quant, Regenxbio's Enterprise Value crashed by 5787.61% in 2021 and then soared by 2451.28% in 2023.
- Regenxbio's Enterprise Value (Quarter) stood at -$457.4 million in 2021, then increased by 20.29% to -$364.6 million in 2022, then rose by 24.51% to -$275.3 million in 2023, then increased by 14.74% to -$234.7 million in 2024, then fell by 16.84% to -$274.2 million in 2025.
- Its Enterprise Value was -$274.2 million in Q3 2025, compared to -$323.3 million in Q2 2025 and -$267.9 million in Q1 2025.